LOADING
Comparing Coca-Cola Company (KO) and Pfizer Inc (PFE) across the Consumer Staples and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | KO | PFE |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $328.3B | $151.7B |
| P/E Ratio | 25.1 | 19.6 |
| Forward P/E | 23.1 | 9.1 |
| PEG Ratio | 3.85 | 13.77 |
| EPS | $3.04 | $1.36 |
| Revenue Growth (YoY) | 2.4% | -1.2% |
| Profit Margin | 27.3% | 12.4% |
| Return on Equity | 43.3% | 8.9% |
| Dividend Yield | 2.73% | 6.42% |
| Beta | 0.36 | 0.39 |
| 52-Week High | $81.44 | $28.75 |
| 52-Week Low | $64.45 | $20.87 |
| Volume | -- | -- |
Coca-Cola Company is the larger company by market capitalization. Pfizer Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Pfizer Inc offers a higher dividend yield for income investors. Coca-Cola Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.